| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.2M | — | -8.5% |
| Cost of Revenue | $7.7M | — | +7.2% |
| R&D Expense | $3.5M | — | +13.2% |
| SG&A Expense | $7.6M | — | -9.1% |
| Operating Income | $2.4M | — | -59.4% |
| Pre-tax Income | $2.6M | — | -58.1% |
| Income Tax | $636K | — | -40.2% |
| Net Income | $2.0M | — | -61.8% |
| EPS (Basic) | $0.10 | — | -60.0% |
| EPS (Diluted) | $0.09 | — | -64.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.1M | -32.4% | -14.1% |
| Accounts Receivable | $19.8M | -12.7% | -4.3% |
| Current Assets | $47.2M | -18.4% | -6.3% |
| Total Assets | $193.9M | -5.9% | -5.2% |
| Current Liabilities | $43.4M | -11.5% | +6.6% |
| Total Liabilities | $52.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.4M | — | +8.4% |
| Capital Expenditures | $604K | — | -18.9% |
| Investing Cash Flow | -$604K | — | +18.9% |
| Financing Cash Flow | -$10.0M | — | +7.0% |
| Free Cash Flow | $1.8M | — | +21.9% |
| +0.4% |
| Stockholders' Equity | $141.0M | -3.7% | -7.1% |